Harvey RD, Rubinstein WS, Ison G, et al. Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis. ASCO Annual Meeting 2019, abstract LBA108.
Lutetium-177 PSMA-617 zet belangrijke stap richting kliniek
nov 2018 | Uro-oncologie